These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Homocysteine-lowering interventions for preventing cardiovascular events. Martí-Carvajal AJ, Solà I, Lathyris D. Cochrane Database Syst Rev; 2015 Jan 15; 1():CD006612. PubMed ID: 25590290 [Abstract] [Full Text] [Related]
5. Interventions for lowering plasma homocysteine levels in dialysis patients. Nigwekar SU, Kang A, Zoungas S, Cass A, Gallagher MP, Kulshrestha S, Navaneethan SD, Perkovic V, Strippoli GF, Jardine MJ. Cochrane Database Syst Rev; 2016 May 31; 2016(5):CD004683. PubMed ID: 27243372 [Abstract] [Full Text] [Related]
6. Interventions for lowering plasma homocysteine levels in kidney transplant recipients. Kang A, Nigwekar SU, Perkovic V, Kulshrestha S, Zoungas S, Navaneethan SD, Cass A, Gallagher MP, Ninomiya T, Strippoli GF, Jardine MJ. Cochrane Database Syst Rev; 2015 May 04; 2015(5):CD007910. PubMed ID: 25938479 [Abstract] [Full Text] [Related]
7. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM. Cochrane Database Syst Rev; 2015 Jan 11; 1():CD008170. PubMed ID: 25577154 [Abstract] [Full Text] [Related]
10. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm. Shantsila E, Lip GY. Cochrane Database Syst Rev; 2016 Sep 15; 9(9):CD003333. PubMed ID: 27629776 [Abstract] [Full Text] [Related]
11. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. De Schryver EL, Algra A, van Gijn J. Cochrane Database Syst Rev; 2003 Sep 15; (1):CD001820. PubMed ID: 12535415 [Abstract] [Full Text] [Related]
12. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus. Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, Sonne DP, Lundstrøm LH, Almdal T. Cochrane Database Syst Rev; 2013 Apr 30; (4):CD009008. PubMed ID: 23633364 [Abstract] [Full Text] [Related]
13. Pharmacological interventions for treating heart failure in patients with chagas cardiomyopathy. Hidalgo R, Martí-Carvajal AJ, Kwong JS, Simancas-Racines D, Nicola S. Cochrane Database Syst Rev; 2012 Nov 14; 11():CD009077. PubMed ID: 23152267 [Abstract] [Full Text] [Related]
14. [Meta-analysis on effect of combined supplementation of folic acid, vitamin B12 and B6 on risk of cardio-cerebrovascular diseases in randomized control trials]. Lan X, Dang SN, Zhao YL, Yan H, Yan H. Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul 14; 37(7):1028-34. PubMed ID: 27453118 [Abstract] [Full Text] [Related]
15. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T, Nigwekar SU, Gallagher MP, Cass A, Strippoli G, Perkovic V. BMJ; 2012 Jun 13; 344():e3533. PubMed ID: 22695899 [Abstract] [Full Text] [Related]
16. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Bostom AG, Carpenter MA, Kusek JW, Levey AS, Hunsicker L, Pfeffer MA, Selhub J, Jacques PF, Cole E, Gravens-Mueller L, House AA, Kew C, McKenney JL, Pacheco-Silva A, Pesavento T, Pirsch J, Smith S, Solomon S, Weir M. Circulation; 2011 Apr 26; 123(16):1763-70. PubMed ID: 21482964 [Abstract] [Full Text] [Related]